Lobeline for smoking cessation.
BACKGROUND: Lobeline is a partial nicotine agonist, which has been used in a variety of commercially available preparations to help stop smoking. OBJECTIVES: The objective of this review was to assess the effects of lobeline on long term smoking cessation. SEARCH STRATEGY: We searched the Cochrane...
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Journal article |
| Hizkuntza: | English |
| Argitaratua: |
2000
|
| _version_ | 1826265853811752960 |
|---|---|
| author | Stead, L Hughes, JR |
| author_facet | Stead, L Hughes, JR |
| author_sort | Stead, L |
| collection | OXFORD |
| description | BACKGROUND: Lobeline is a partial nicotine agonist, which has been used in a variety of commercially available preparations to help stop smoking. OBJECTIVES: The objective of this review was to assess the effects of lobeline on long term smoking cessation. SEARCH STRATEGY: We searched the Cochrane Tobacco Addiction Group trials register. SELECTION CRITERIA: Randomized trials comparing lobeline to placebo or an alternative therapeutic control, which reported smoking cessation with at least six months follow-up. DATA COLLECTION AND ANALYSIS: We extracted data in duplicate on the type of subjects, the dose and form of lobeline, the outcome measures, method of randomisation, and completeness of follow-up. MAIN RESULTS: We identified no trials meeting the full inclusion criteria including long term follow-up. REVIEWER'S CONCLUSIONS: There is no evidence available from long term trials that lobeline can aid smoking cessation. |
| first_indexed | 2024-03-06T20:30:09Z |
| format | Journal article |
| id | oxford-uuid:30c22757-da7b-46f4-9fc2-3fe431749c7f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:30:09Z |
| publishDate | 2000 |
| record_format | dspace |
| spelling | oxford-uuid:30c22757-da7b-46f4-9fc2-3fe431749c7f2022-03-26T13:03:34ZLobeline for smoking cessation.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:30c22757-da7b-46f4-9fc2-3fe431749c7fEnglishSymplectic Elements at Oxford2000Stead, LHughes, JR BACKGROUND: Lobeline is a partial nicotine agonist, which has been used in a variety of commercially available preparations to help stop smoking. OBJECTIVES: The objective of this review was to assess the effects of lobeline on long term smoking cessation. SEARCH STRATEGY: We searched the Cochrane Tobacco Addiction Group trials register. SELECTION CRITERIA: Randomized trials comparing lobeline to placebo or an alternative therapeutic control, which reported smoking cessation with at least six months follow-up. DATA COLLECTION AND ANALYSIS: We extracted data in duplicate on the type of subjects, the dose and form of lobeline, the outcome measures, method of randomisation, and completeness of follow-up. MAIN RESULTS: We identified no trials meeting the full inclusion criteria including long term follow-up. REVIEWER'S CONCLUSIONS: There is no evidence available from long term trials that lobeline can aid smoking cessation. |
| spellingShingle | Stead, L Hughes, JR Lobeline for smoking cessation. |
| title | Lobeline for smoking cessation. |
| title_full | Lobeline for smoking cessation. |
| title_fullStr | Lobeline for smoking cessation. |
| title_full_unstemmed | Lobeline for smoking cessation. |
| title_short | Lobeline for smoking cessation. |
| title_sort | lobeline for smoking cessation |
| work_keys_str_mv | AT steadl lobelineforsmokingcessation AT hughesjr lobelineforsmokingcessation |